← Back to Search

Virtual Reality for End-of-Life Care

N/A
Recruiting
Led By Catherine Mann, EdD
Research Sponsored by State University of New York at Buffalo
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients who are hospice care eligible as defined by the Medicare Hospice benefit and receive hospice or palliative care from Hospice and Palliative Care Buffalo.
Must not have
They are not 18 years old.
Their Palliative Performance Score (PPS) is below 30.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up two weeks
Awards & highlights

Summary

This trial studies how virtual reality can help ease symptoms, with people rating presence and symptom severity before and after VR sessions.

Who is the study for?
This trial is for hospice-eligible patients receiving care from Hospice and Palliative Care Buffalo. Participants must be cognitively intact, have a Palliative Performance Score (PPS) of 30 or above, and not suffer from severe hearing, vision, speech impairments, dizziness, nausea, headaches, migraines seizures or motion sickness. They must speak English and be at least 18 years old.
What is being tested?
The study tests how personalized virtual reality experiences affect symptom severity in end-of-life conditions. It measures changes in symptoms before and after VR sessions as well as the sense of presence within VR to see if it's linked to symptom relief.
What are the potential side effects?
Since this intervention involves virtual reality experiences rather than medication or invasive procedures, typical side effects may include temporary discomfort like dizziness or nausea during VR use.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am eligible for hospice care and receiving it from Hospice and Palliative Care Buffalo.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am under 18 years old.
Select...
My ability to care for myself is severely limited.
Select...
I have uncorrected issues with my hearing, vision, or speech.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~two weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and two weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Edmonton Symptom Assessment System - Revised (ESAS)
Secondary study objectives
igroup presence questionnaire (IPQ)

Trial Design

1Treatment groups
Experimental Treatment
Group I: Single-Arm Open PilotExperimental Treatment1 Intervention
Pre- Post-intervention design. The intervention that participants will be experiencing is personalized virtual reality experiences. The content of this experience will be determined at the initial visit during which the participant will complete a preference questionnaire which identifies the location they want to "go" to. These experiences will be filmed on the insta360 One R camera by the research coordinator. Each experience will be approximately 20 minutes. To view the videos participants will wear the Oculus Quest 2 virtual reality headset.

Find a Location

Who is running the clinical trial?

State University of New York - Upstate Medical UniversityOTHER
173 Previous Clinical Trials
27,417 Total Patients Enrolled
2 Trials studying Anxiety
43 Patients Enrolled for Anxiety
State University of New York at BuffaloLead Sponsor
264 Previous Clinical Trials
52,060 Total Patients Enrolled
1 Trials studying Anxiety
4,025 Patients Enrolled for Anxiety
Catherine Mann, EdDPrincipal InvestigatorSUNY Buffalo
~4 spots leftby Nov 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top